ADAR1 Capital Management »

Stryker Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Stryker Corporation (SYK) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Stryker Corporation

Tip: Access up to 7 years of quarterly data

All positions including Stryker Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stryker Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $630k 2.0k 314.84

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Stryker Corporation

BlackRock
Vanguard Capital Management
Jpmorgan Chase & Co
State Street Corporation
Greenleaf Trust
T. Rowe Price Associates
Vanguard Portfolio Management
Wellington Management Company
Geode Capital Management
Morgan Stanley
Alliancebernstein
Norges Bank Investment Management
Bank of America Corporation
Royal Bank of Canada
Bank of New York Mellon

View all funds holding Stryker Corporation